Recombinant vesicular stomatitis virus vectors as oncolytic agents in the treatment of high-grade gliomas in an organotypic brain tissue slice-glioma coculture model

Journal of Neurosurgery

Volumn 100, Issue 6, 2004, Pages 1049-1059

  Duntsch, Christopher D ^a   Zhou, Qihong ^b   Jayakar, Himangi R ^b   Weimar, James D ^b   Robertson, Jon H ^b   Pfeffer, Lawrence M ^b   Wang, Lie ^b   Xiang, Zixiu ^b   Whitt, Michael A ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NONE

Author keywords

C6 glioma; Oncolytic therapy; Organotypic culture; Rat; Vesicular stomatitis virus

Indexed keywords

BETA INTERFERON; MICROTUBULE ASSOCIATED PROTEIN 2; ONCOLYTIC VIRUS; RED FLUORESCENT PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CELL STRAIN C6; CELL STRAIN U87; COCULTURE; CONTROLLED STUDY; ENVELOPE GENE; GENE THERAPY; GLIOMA; GLIOMA CELL; GLYCOPROTEIN GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MODEL; NEUROTOXICITY; NONHUMAN; ONCOLYTIC THERAPY; PRIORITY JOURNAL; RAT; SYNAPSE; TUMOR CELL LINE; VESICULAR STOMATITIS VIRUS; VESICULAR STOMATITIS VIRUS VECTOR; VIRUS RECOMBINANT; VIRUS REPLICATION; WILD TYPE;

EID: 2442712715     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2004.100.6.1049     Document Type: Article

References (42)

1. Abril E, Mendez RE, Garcia A, et al: Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon. Tissue Antigens 47:391-398, 1996
2. Bahr BA: Long-term hippocampal slices: a model system for investigating synaptic mechanisms and pathologic processes. J Neurosci Res 42:294-305, 1995
3. Balachandran S, Barber GN: Vesicular stomatitis virus (VSV) therapy of tumors. IUBMB Life 50:135-138, 2000
4. Balachandran S, Porosnicu M, Barber GN: Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis. J Virol 75:3474-3479, 2001
5. Balachandran S, Roberts PC, Kipperman T, et al: Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J Virol 74: 1513-1523, 2000
6. Bischoff JR, Kirn DH, Williams A, et al: An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373-376, 1996
7. Crain SM: Neurophysiologic Studies in Tissue Culture. New York: Raven Press, 1976
8. DeAngelis LM, Burger PC, Green SB, et al: Malignant glioma: who benefits from adjuvant chemotherapy? Ann Neurol 44: 691495, 1998
9. Fernandez M, Porosnicu M, Markovic D, et al: Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease. J Virol 76:895-904, 2002
10. Fine HA, Figg WD, Jaeckle K, et al: Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. J Clin Oncol 18:708-715, 2000
11. Gadaleta P, Vacotto M, Coulombie F: Vesicular stomatitis virus induces apoptosis at early stages in the viral cycle and does not depend on virus replication. Virus Res 86:87-92, 2002
12. Gahwiler BH: Organotypic monolayer cultures of nervous tissue. J Neurosci Methods 4:329-342, 1981
13. Gahwiler BH: Slice cultures of cerebellar, hippocampal and hypothalamic tissue. Experientia 40:235-243, 1984
14. Gahwiler BH, Capogna M, Debanne D, et al: Organotypic slice cultures: a technique has come of age. Trends Neurosci 20: 471-477, 1997
15. Grant R, Liang BC, Page MA, et al: Age influences chemotherapy response in astrocytomas. Neurology 45:929-933, 1995
16. Green SB, Byar DP, Walker MD, et al: Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67:121-132, 1983
17. Hobbs JA, Hommel-Berrey G, Brahmi Z: Requirement of caspase-3 for efficient apoptosis induction and caspase-7 activation but not viral replication or cell rounding in cells infected with vesicular stomatitis virus. Hum Immunol 64:82-92, 2003
18. Jayakar HR, Murti KG, Whitt MA: Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol 74:9818-9827, 2000
19. Jayakar HR, Whitt MA: Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology. J Virol 76:8011-8018, 2002
20. Jemal A, Thomas A, Murray T, et al: Cancer statistics, 2002. Ca Cancer J Clin 52:234-47, 2002
21. Kopecky SA, Willingham MC, Lyles DS: Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus. J Virol 75:12169-12181, 2001
22. Mullen JT, Tanabe KK: Viral oncolysis. Oncologist 7:106-119, 2002
23. Muller M, Gahwiler BH, Rietschin L, et al: Reversible loss of dendritic spines and altered excitability after chronic epilepsy in hippocampal slice cultures. Proc Natl Acad Sci USA 90:257-261, 1993
24. Muller U, Steinhoff U, Reis LF, et al: Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921, 1994
25. Nelson DF, Diener-West M, Weinstein AS, et al: A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study. Int J Radiat Oncol Biol Phys 12:1793-1800, 1986
26. Plenz D, Kitai ST: Organotypic cortex-striatum-mesencephalon cultures: the nigrostriatal pathway. Neurosci Lett 209:177-180, 1996
27. Plenz D, Kitai ST: Up and down states in striatal medium spiny neurons simultaneously recorded with spontaneous activity in fast-spiking interneurons studied in cortex-striatum-substantia nigra organotypic cultures. J Neurosci 18:266-283, 1998
28. Plenz D, Kital ST: A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 400: 677-682, 1999
29. Rabinowitz SG, Johnson TC, Dal Canto MC: The uncoupled relationship between the temperature-sensitivity and neurovirulence in mice of mutants of vesicular stomatitis virus. J Gen Virol 35: 237-249, 1977
30. Rimvall K, Keller F, Waser PG: Selective kainic acid lesions in cultured explants of rat hippocampus. Acta Neuropathol 74: 183-190, 1987
31. Robison CS, Whitt MA: The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly. J Virol 74:2239-2246, 2000
32. Stojdl DF, Lichty B, Knowles S, et al: Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 6:821-825, 2000
33. Stoppini L, Buchs PA, Muller D: A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-182, 1991
34. Surawicz TS, Davis F, Freels S, et al: Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 40:151-160, 1998
35. van den Pol AN, Dalton KP, Rose JK: Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein. J Virol 76:1309-1327, 2002
36. Vornov JJ, Tasker RC, Coyle JT: Direct observation of the agonist-specific regional vulnerability to glutamate, NMDA, and kainate neurotoxicity in organotypic hippocampal cultures. Exp Neurol 114:11-22, 1991
37. Walker MD, Alexander E Jr, Hunt WE, et al: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49:333-343, 1978
38. Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323-1329, 1980
39. Wong LH, Krauer KG, Hatzinisiriou I, et al: Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-iSGF3gamma. J Biol Chem 272: 28779-28785, 1997
40. Yang CH, Murti A, Pfeffer SR, et al: IFNalpha/beta promotes cell survival by activating NF-kappa B. Proc Natl. Acad Sci USA 97: 13631-13636, 2000
41. Zhou Q, Abe H, Nowak TS Jr: Immunocytochemical and in situ hybridization approaches to the optimization of brain slice preparations. J Neurosci Methods 59:85-92, 1995
42. Zimmer J, Kristensen BW, Jakobsen B, et al: Excitatory amino acid neurotoxicity and modulation of glutamate receptor expression in organotypic brain slice cultures. Amino Acids 19:7-21, 2000